Clinical efficacy of Crataegus extract WS(R)1442 in congestive heart failure NYHA class II. Phytomedicine. 2001;8:262- 266.G. Z.Jun,"Clinical efficacy of Crataegusextract WS(R) 1442 in congestive heart failure NYHA class II"Phytomedicine. 2001,8(4):262- 266....
NYHA functional class I 10 (12.8%) II 33 (42.3%) III 26 (33.3%) IV 9 (11.5%) Ischemic cardiomyopathy 24 (30.8%) Rest heart rate beats/min 77 ± 15 (44–110) Mean blood pressure mm Hg 88 ± 13 (62–123) LV ejection fraction % 36 ± 15 (10–59) Mean PCWP mm Hg 15 ± ...
( p <.01), chronic renal failure ( p = .01), diabetes ( p = .04), and chronic obstructive pulmonary disease ( p = .04). there was no difference in readmissions between the groups when stratifying for nyha class or left ventricular function. the intervention group also had significantly...
in comparison to placebo and open titrated digoxin in patients with mild congestive heart failure NYHA class I and II. A total of 60 patients (22 males and 38 females) were evaluated for body weight, signs and symptoms score and the need for additional diuretic treatment for adequate symptom ...
(LVESD), and left ventricular end diastolic diameter(LVEDD) and change in New York Heart Association (NYHA) functional class over a period of 12months since the initiation of therapy.RESULTS:Heart rate, systolic diastolic blood pressure, LVEF, LVEDD and LVESD at baseline and after 12 monthswere...
stive Heart Failure Summary : Effects of CHF Therapies on Outcomes Congestive Heart FailureSummary : Effects of CHF Therapies on Outcomes Congestive Heart FailureIiib, Nyhafc
(LV) function during exercise in patients with ischemic heart disease (IHD) and idiopathic dilated cardiomyopathy (DCM) are controversial.Patients and methods:patients with stable congestive heart failure (CHF) (New York heart association [NYHA] class II and III) and ejection fraction (EF)...
Indication of worsening health condition in patients with congestive heart failure using the analysis of the speed and pattern of temperature change in a way that is individualized toward patient's he
(TIME-CHF) of 499 patients aged 60 years or older with systolic heart failure (ejection fraction ≤45%), New York Heart Association (NYHA) class of II or greater, prior hospitalization for heart failure within 1 year, and N-terminal BNP level of 2 or more times the upper limit of ...
These patients were divided into two groups; CHF (44 patients) in NYHA class I-III, and non CHF (56 patients). We measured D-sorbitol in erythrocytes and fasting plasma level of glucose (FBS) in these patients. There was a significant difference of D-sorbitol level in erythrocytes between...